Addendum: The chromatographic constitution of andiroba oil and its healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option

Jessica T. Gomes; Ana Márcia V. Wanzeler; Sergio M.A. Júnior; Rosa Helena F. Chaves Soares; Carolina P. de Oliveira; Emanuelle de M. Rodrigues; Bruno M. Soares; Diego D.F.A. Alcantara; Rommel M.R. Burbano; Fabrício M. Tuji

doi:10.18632/oncotarget.28504

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Addendum:

Addendum: The chromatographic constitution of andiroba oil and its healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option

PDF | How to cite

Oncotarget. 2023; 14:824-824. https://doi.org/10.18632/oncotarget.28504

Metrics: PDF 502 views | ?

Jessica T. Gomes¹, Ana Márcia V. Wanzeler¹, Sergio M.A. Júnior¹, Rosa Helena F. Chaves Soares², Carolina P. de Oliveira², Emanuelle de M. Rodrigues², Bruno M. Soares³, Diego D.F.A. Alcantara³, Rommel M.R. Burbano³ and Fabrício M. Tuji¹

¹Department of Dentistry, Federal University of Pará, Guamá, Belém, Pará 66075-970, Brazil
²Department of Medicine, University Center of Pará, Souza, Belém, Pará 66613-903, Brazil
³Department of Genetics, Laboratory of Human Cytogenetics, Federal University of Pará, Guamá, Belém, Pará 66075-970, Brazil

Published: September 22, 2023

Copyright: © 2023 Gomes et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has an addendum: Acknowledgements - To the Experimental Research Group and the Laboratory of Histopathology of the State University of Pará (CESUPA) for the technical assistance provided and to the Laboratory of Human Cytogenetics of the Federal University of Pará (LCH/UFPA). This study was also supported in part by scholarships for postgraduate students of Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES) - Finance Code 001. To the support of PROPESP/UFPA (PAPQ) (23073.074981/2022-97).

Original article: Oncotarget. 2023; 14:23-39. DOI: https://doi.org/10.18632/oncotarget.28338.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28504

Publication Alerts

Post-Publication Promotion

Publication Discount

Addendum:

Addendum: The chromatographic constitution of andiroba oil and its healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option